Emma C Johnson1, Yoonhoo Chang2, Arpana Agrawal1. 1. Department of Psychiatry, Washington University School of Medicine, Saint Louis, MO. 2. Division of Biology and Biomedical Sciences, Washington University School of Medicine, Saint Louis, MO.
Abstract
PURPOSE OF THE REVIEW: Sample size increases have resulted in novel and replicable loci for substance use disorders (SUDs). We summarize some of the latest insights into SUD genetics and discuss some next steps in addiction genetics. RECENT FINDINGS: Genome-wide association studies have substantiated the role of previously known variants (e.g., rs1229984 in ADH1B for alcohol) and identified several novel loci for alcohol, tobacco, cannabis, opioid and cocaine use disorders. SUDs are genetically correlated with psychiatric outcomes, while liability to substance use is inconsistently associated with these outcomes and more closely associated with lifestyle factors. Specific variant associations appear to differ somewhat across populations, although similar genes and systems are implicated. SUMMARY: The next decade of human genetic studies of addiction should focus on expanding to non-European populations, consider pleiotropy across SUD and with other psychiatric disorders, and leverage human and cross-species functional data to elucidate the biological mechanisms underlying SUDs.
PURPOSE OF THE REVIEW: Sample size increases have resulted in novel and replicable loci for substance use disorders (SUDs). We summarize some of the latest insights into SUD genetics and discuss some next steps in addiction genetics. RECENT FINDINGS: Genome-wide association studies have substantiated the role of previously known variants (e.g., rs1229984 in ADH1B for alcohol) and identified several novel loci for alcohol, tobacco, cannabis, opioid and cocaine use disorders. SUDs are genetically correlated with psychiatric outcomes, while liability to substance use is inconsistently associated with these outcomes and more closely associated with lifestyle factors. Specific variant associations appear to differ somewhat across populations, although similar genes and systems are implicated. SUMMARY: The next decade of human genetic studies of addiction should focus on expanding to non-European populations, consider pleiotropy across SUD and with other psychiatric disorders, and leverage human and cross-species functional data to elucidate the biological mechanisms underlying SUDs.
Entities:
Keywords:
Substance use disorders; addiction genetics; genome-wide association studies; psychiatric genetics; single-nucleotide polymorphism; statistical genetics
Authors: Louisa Degenhardt; Harvey A Whiteford; Alize J Ferrari; Amanda J Baxter; Fiona J Charlson; Wayne D Hall; Greg Freedman; Roy Burstein; Nicole Johns; Rebecca E Engell; Abraham Flaxman; Christopher J L Murray; Theo Vos Journal: Lancet Date: 2013-08-29 Impact factor: 79.321
Authors: Laura Jean Bierut; Jerry A Stitzel; Jen C Wang; Anthony L Hinrichs; Richard A Grucza; Xiaoling Xuei; Nancy L Saccone; Scott F Saccone; Sarah Bertelsen; Louis Fox; William J Horton; Naomi Breslau; John Budde; C Robert Cloninger; Danielle M Dick; Tatiana Foroud; Dorothy Hatsukami; Victor Hesselbrock; Eric O Johnson; John Kramer; Samuel Kuperman; Pamela A F Madden; Kevin Mayo; John Nurnberger; Ovide Pomerleau; Bernice Porjesz; Oliver Reyes; Marc Schuckit; Gary Swan; Jay A Tischfield; Howard J Edenberg; John P Rice; Alison M Goate Journal: Am J Psychiatry Date: 2008-06-02 Impact factor: 18.112
Authors: Yonwoo Jung; Lawrence S Hsieh; Angela M Lee; Zhifeng Zhou; Daniel Coman; Christopher J Heath; Fahmeed Hyder; Yann S Mineur; Qiaoping Yuan; David Goldman; Angelique Bordey; Marina R Picciotto Journal: Nat Neurosci Date: 2016-05-30 Impact factor: 24.884
Authors: Henry R Kranzler; Hang Zhou; Rachel L Kember; Rachel Vickers Smith; Amy C Justice; Scott Damrauer; Philip S Tsao; Derek Klarin; Aris Baras; Jeffrey Reid; John Overton; Daniel J Rader; Zhongshan Cheng; Janet P Tate; William C Becker; John Concato; Ke Xu; Renato Polimanti; Hongyu Zhao; Joel Gelernter Journal: Nat Commun Date: 2019-04-02 Impact factor: 14.919
Authors: Alize J Ferrari; Fiona J Charlson; Rosana E Norman; Scott B Patten; Greg Freedman; Christopher J L Murray; Theo Vos; Harvey A Whiteford Journal: PLoS Med Date: 2013-11-05 Impact factor: 11.069
Authors: Romain Icick; Alexey Shadrin; Børge Holen; Naz Karadag; Aihua Lin; Guy Hindley; Kevin O'Connell; Oleksandr Frei; Shahram Bahrami; Margrethe Collier Høegh; Weiqiu Cheng; Chun C Fan; Srdjan Djurovic; Anders M Dale; Trine Vik Lagerberg; Olav B Smeland; Ole A Andreassen Journal: Neuropsychopharmacology Date: 2022-08-11 Impact factor: 8.294